In Vivo Screening Identifies Esr1 As A Clinically Relevant Target For Radiosensitization In Hnscc

International Journal of Radiation Oncology*Biology*Physics(2018)

Cited 0|Views13
No score
Abstract
Targeting of Estrogen Receptor 1 (ESR1) has been part of the mainstay of treatment for estrogen receptor-positive (ER+) breast cancers. However, the significance of ESR1 in other malignancies is unclear.
More
Translated text
Key words
vivo screening identifies esr1,radiosensitization,clinically relevant target
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined